Physicians' Academy for Cardiovascular Education

Working towards eradication of CV risk

10' education - Dec. 15, 2021 - Prof. Erik Stroes, MD, PhD - Amsterdam, The Netherlands

Achieving LDL-c target, measurements of risk factors, and a need for tailored therapy choices are three important factors to reduce (residual) CV risk. Prof. Stroes briefly discusses these three topics.

Video navigation menu

  • Achieving target LDL-c 0:08
  • The risk factor Lp(a) 2:30
  • Six pillars of (residual) CV risk 3:49


Prof. Erik Stroes, MD, PhD is professor of Vascular Medicine at Amsterdam University Medical Centers in Amsterdam, The Netherlands.


This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: